Another very interesting discovery from the same research group was that tyrosine kinase inhibitors including IM stimulate ABCA3 expression via the embryonic stem cell-associated transcription factor SALL4 in both model CML cells and primary CML cells [66]. This evidence concerns the gene SALL4 and chronic myelogenous leukemia, BCR-ABL1 positive.